Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Comment by drjekylon Feb 17, 2017 2:47pm
150 Views
Post# 25862736

RE:RE:RE:RE:reality check

RE:RE:RE:RE:reality checkaarcor, that tailwinds "report" is about as real as "$18 and 4, maybe more"!
the company needs money to get there and lots of it. big companies don't do what armchair bullboard posting wanna be ceos think they should. they do what's good for them.
for now, tailwinds and the share price are telling me the same thing i.e. nothing is happening.
these are my thoughts, not yours, i'm................
#toindwbmahbn
drj!
Bullboard Posts